Armata Pharmaceuticals, Inc. (ARMP) Share-based Payment Arrangement, Expense USD 2013 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Armata Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2024.
Armata Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2024 was $534 K, a 37.7% decline year-over-year.
Armata Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2024 was $615 K, a 82.3% decline year-over-year.
Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $938 K, a 69.8% decline from 2022.
Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.11 M, a 7.74% increase from 2021.
Armata Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.88 M, a 17.1% decline from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$615 K	$534 K	-$323 K	-37.7%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$938 K	$193 K	-$624 K	-76.4%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-21
Q3 2023	$1.56 M	-$373 K	-$1.22 M	-144%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$2.78 M	$261 K	-$688 K	-72.5%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$3.47 M	$857 K	+$364 K	+73.8%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	$3.11 M	$817 K	+$153 K	+23%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-21
Q3 2022	$2.95 M	$846 K	+$377 K	+80.4%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	$2.58 M	$949 K	+$42 K	+4.63%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	$2.53 M	$493 K	-$349 K	-41.4%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q4 2021	$2.88 M	$664 K	-$198 K	-23%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-16
Q3 2021	$3.08 M	$469 K	-$194 K	-29.3%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021	$3.27 M	$907 K	+$1 K	+0.11%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	$3.27 M	$842 K	-$202 K	-19.3%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	$3.48 M	$862 K	-$87 K	-9.17%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-17
Q3 2020	$3.56 M	$663 K	-$1.84 M	-73.5%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-10
Q2 2020	$5.4 M	$906 K	+$182 K	+25.1%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-12
Q1 2020	$5.22 M	$1.04 M	+$945 K	+955%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	$4.27 M	$949 K	+$1.05 M		Oct 1, 2019	Dec 31, 2019	10-K	2021-03-18
Q3 2019	$3.22 M	$2.5 M	+$2.49 M	+31125%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	$734 K	$724 K	+$711 K	+5469%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	$23 K	$99 K	-$23 K	-18.9%	Jan 1, 2019	Mar 31, 2019	10-Q	2019-05-06
Q4 2018	$46 K	-$97 K	-$229 K	-173%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-19
Q3 2018	$275 K	$8 K	-$90 K	-91.8%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	$365 K	$13 K	-$286 K	-95.7%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-14
Q1 2018	$651 K	$122 K	-$49 K	-28.7%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-06
Q4 2017	$700 K	$132 K	-$165 K	-55.6%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-25
Q3 2017	$865 K	$98 K	-$236 K	-70.7%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-08
Q2 2017	$1.1 M	$299 K	-$249 K	-45.4%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-09
Q1 2017	$1.35 M	$171 K	-$645 K	-79%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-15
Q4 2016	$2 M	$297 K	+$67 K	+29.1%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-14
Q3 2016	$1.93 M	$334 K	+$185 K	+124%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-14
Q2 2016	$1.74 M	$548 K	+$496 K	+954%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-14
Q1 2016	$1.25 M	$816 K	+$764 K	+1469%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-15
Q4 2015	$483 K	$230 K	+$171 K	+290%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-27
Q3 2015	$312 K	$149 K	-$1.26 M	-89.4%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-10
Q2 2015	$1.57 M	$52 K	-$183 K	-77.9%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-15
Q1 2015	$1.75 M	$52 K	-$182 K	-77.8%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-12
Q4 2014	$1.94 M	$59 K	-$173 K	-74.6%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-30
Q3 2014	$2.11 M	$1.41 M	+$1.16 M	+468%	Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-16
Q2 2014	$949 K	$235 K	-$568 K	-70.7%	Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-13
Q1 2014	$1.52 M	$234 K	+$80 K	+51.9%	Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-15
Q4 2013	$1.44 M	$232 K			Oct 1, 2013	Dec 31, 2013	10-K	2015-04-15
Q3 2013		$248 K			Jul 1, 2013	Sep 30, 2013	10-Q/A	2015-04-15
Q2 2013		$803 K			Apr 1, 2013	Jun 30, 2013	10-Q/A	2015-04-15
Q1 2013		$154 K			Jan 1, 2013	Mar 31, 2013	10-Q/A	2015-04-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.